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ABSTRACT
Affinity Precipitation Using Thermo-Responsive, Water-Soluble Polymers as Matrix;
Synthetic Studies Toward the Ageliferins
(December 2003)
Min Zhou, B.S., Beijing Medical University, P.R. China
Chair of Advisory Committee: Dr. Daniel Romo
Isolated from marine sponges, many bromopyrrole alkaloids have become
natural products of intense scientific interest.  The oroidin-derived class of dimeric
bromopyrrole alkaloids that include ageliferin, bromoageliferin, and dibromoageliferin
exhibit interesting biological properties, including actomycin ATPase, antiviral and
antibacterial activities.
As a prelude to the total synthesis of ageliferin, an intramolecular Diels-Alder
(IMDA) reaction was explored as a means to introduce the three contiguous
stereocenters.  Toward this end, various IMDA precursors were synthesized, and several
strategies for the synthesis of  IMDA substrates were devised and explored.
Affinity chromatography is a powerful technique that enables the purification of
a specific protein from a complex mixture.  However, traditional affinity
chromatography techniques are somewhat limited due to the solid state of the matrix.  To
overcome these limitations, the utility of a soluble polymer as an alternative affinity
matrix was explored for the isolation of natural product receptors.  This polymer
displays physical properties that make it an ideal matrix for protein isolation and
iv
purification.  The parent polymer is soluble in aqueous solution at 4 °C and precipitates
once the mixture reaches 32 °C. Furthermore, employing this polymer for affinity
chromatography may limit the nonspecific binding of proteins. It is also possible to
determine the ligand loading using standard analytical techniques such as 1H and 13C
NMR.  For proof of concept, a dexamethasone-containing macroligand was synthesized
to isolate the known glucocorticoid receptor.  In addition, a cyclosporin A-containing
macroligand was synthesized and employed to isolate the well known and more robust
cyclophilins.  In this work, it was demonstrated that indeed the ligand loading can be
determined by 1H NMR technique.   In addition, it was established, as expected, that the
water solubility of the macroligands varies based on the hydrophilicity and
hydrophobicity of the ligand and degree of ligand  loading.
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1CHAPTER I
AN  INTRODUCTION  TO THE OROIDIN DERIVED BROMOPYRROLE
ALKALOIDS :  AGELIFERIN, BROMOAGELIFERIN,
DIBROMOAGELIFERIN, SCEPTRIN AND DIBROMOSCEPTRIN
1. Introduction
Traditionally, soils, plants and micro-organisms have been fertile sources for the
isolation and identification of many biological active molecules.  However, during the
last few decades, the oceans have also become recognized as an  abundant source of
bioactive natural products.  A vast array of oceanic organisms including sponges, algae,
microorganisms, mollusks have provided structurally novel and diverse natural products
that display equally interesting bioactivity.1  From all the marine organisms mentioned
above, sponges have been the most thoroughly investigated species.2  Biosynthetically
related to oroidin (1) and hymenidin (2), the family of bromopyrrole alkaloids found in
Caribbean sponges Agelas conifera and Agelas n. sp. have aroused scientific interest as a
result of their novel chemical architecture and potential therapeutic value (Figure 1).3,4
                                                
  This thesis follows the style and format of the Journal of the American Chemical Society.
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Figure 1. Structures of oroidin and hymenidin
Oroidin was first isolated by Minale from Agelas oroides.5  During the following ten
years, several scientists including Minale, Garcia and Faulkner tried to assign the
structure of oroidin.5,6,7  Finally, Faulkner and co-workers employed x-ray
crystallography to elucidate the structure of oroidin (1).7
2. Isolation and Bioactivity
The oroidin alkaloid family of marine natural products include the ageliferins and
sceptrins. These marine metabolites display varying degrees of chemical structures and
bromination, highlighting the chemical diversity of natural products isolated from the
ocean (Figure 2).8
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Figure 2. Structures of sceptrins and ageliferins
Harvested from the sponges Agelas coniferin and A. cf. Mauritiana, ageliferin 6,
bromoageliferin 7 and dibromoageliferin 8 were first reported by Rinehart and co-
workers in 1989.9  Subsequently, Kobayashi isolated ageliferins from an Okinawan
sponge Agelas sp., established the structures of compounds 6-8, and studied their
biological activity.8  The marine sponge Agelas sp. was collected in Kerama Islands,
Okinawa.  A  total of 700 grams of sponge were first extracted with methanol and then
partitioned between ethyl acetate and water.  The ethyl acetate-soluble fractions were
subjected to a series of chromatographic purifications, ODS column to furnish ageliferin
6 (0.02% wet weight), bromoageliferin 7 (0.01%), and dibromoageliferin 8 (0.01%).
The relative structure of the ageliferins was established from detailed analysis of the 1H
and 13C NMR data, IR, UV, and high-resolution FABMS analysis comparison with the
spectra of sceptrin 3, oroidin 1 and hymenidin 2.  All 1H and 13C NMR signals of
ageliferin were assigned from two-dimensional  1H-1H DQF-COSY, HMQC, HMBC
spectra, and one-dimentional double and triple resonance experiments.  The C-9, C-9’
4and C-10 substituents of the central cyclohexene ring of ageliferin were all determined to
occupy equatorial positions based on analysis of the 1H-1H coupling constants,
characteristic of trans-diaxial protons ( J9,10 = 7 Hz, J9,9’ = 8 Hz and J9’,10’a = 8 Hz) (
Figure 3).8
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J9,10 = 7 Hz, J9 ,9' = 8 Hz, and J9 ',10 'a = 8 Hz
Figure 3.  1H-1H coupling constants (J/Hz) for the cyclohexene  ring of ageliferin
The actin-myosin protein complex is involved in muscle contraction and other
cell-motility events.  The energy source for these cell motility events comes from
myosin ATPase.  Experiments have shown that the ageliferins are potent actomyosin
ATPase activators.  Furthermore, it was demonstrated that the ATPase activity of rabbit
skeletal muscle myofibrils was elevated to 150, 190 and 200% of the control value by
ageliferin (30 m M), bromoageliferin (1 m M) and dibromoageliferin (1 m M) respectively.8
According to this report, the ageliferins may be useful as chemical tools for biological
studies of the molecular mechanism of actin-myosin contractile systems.
Faulkner and Clardy reported the isolation, structure and bioactivity of sceptrin
(3), isolated from the sponge Agelas sceptrum  collected at Glover Reef, Belize (Figure
2).10  The lyophilized sponge was extracted with hexane, dichloromethane, and methanol
5and  the acetone-insoluble portion of the methanolic extracts were submitted to
chromatography on Sephadex LH-20 twice followed by a LiChrosorb DIOL column to
obtain oroidin (0.5% dry weight) and sceptrin (2.1% dry weight).10  Antimicrobial assays
of sceptrin revealed a broad range of antimicrobial activity against Staphylococcus
aureus, Bacillus subtilis, Candida albicans, Pseudomonas aeruginosa, Alternaria sp.
(fungus), and Cladosporium cucumerinum.10
3.  Biosynthesis
Several proposals for the biosynthesis of ageliferins 6-8 and sceptrins 3-5 have
been suggested.  Sceptrin 3 is structurally derived from hymenidin 2 by way of a head to
head [ 2+2]  cycloaddition of 2 (Scheme 1).3  Along the same lines, the gross structure of
ageliferin is considered to arise from [ 4+2]  cycloaddition of two molecules of hymenidin
(2) followed by double-bond isomerization.3,8  However, Faulkner and Clardy suggested
that a simple photodimerization of hymenidin in the biosynthetic pathway was unlikely
due to insufficient light at the ocean depths where Agelas sceptrum was harvested and
the optical activity of sceptrin is suggestive of enzyme involvement in the biosynthesis
from achiral hymenidin.10  
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4. Previous Synthetic Studies
Publications detailing synthetic approaches toward the ageliferins have so far
been limited to two reports with a total synthesis remaining elusive.11a,11b  Ohta reported
an elegant biomimetic synthesis of racemic 12,12’-dimethylageliferin (13) via an
intermolecular Diels-Alder (DA) dimerization of vinyl-imidazoles (Scheme 2).11a  The
Diels-Alder substrate alkenyl imidazole 10 was obtained from capture of the lithio anion
7by DMF followed by Horner-Wadsworth-Emmons olefination of the aldehyde.  Heating
vinyl imidazole 10 in xylene at 140 ° C for 30 hours produced 11 in moderate yield with
high levels of regio- and facial selectivity (exo/endo = 50:1).  During the course of the
Diels-Alder cycloaddition, double bond isomerization occurs driven by regeneration of
aromaticity of the imidazole ring.  Functional group manipulation gave bis-
azidoimidazole 12. This intermediate was elaborated to unnatural, racemic 12, 12’-
dimethylageliferin 13 in five steps.
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More recently, Lovely has investigated the intramolecular Diels-Alder reactions of
unsaturated amides derived from urocanic acid to provide trans ring-fused products as
the major adduct  via an endo transition state (Scheme 3).11b  Interestingly, cycloadducts
815 and 16  contain the proper structural and stereochemical elements for subsequent
conversion to ageliferin.
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5. Conclusion
The family of bromopyrrole-imidazole alkaloids found in marine sponges have
challenged the synthetic community due to their intriguing structural complexity and
diversity as well as their remarkably wide range of biological activity.  Several proposals
for their biosynthetic origins including intermolecular [ 2+2]  and [ 4+2]  cycloaddition
have been suggested. To date, two approaches have enabled the synthesis of unnatural
(+/-)-12,12’-N,N’-dimethylageliferin and potential ageliferin precursor via inter- and
intramolecular Diels-Alder processes.
9CHAPTER II
SYNTHETIC INVESTIGATIONS OF AGELIFERIN
1. Retrosynthesis Analysis of Ageliferin
 The strategy for a synthesis of ageliferin is centered on the intramolecular Diels-
Alder (IMDA) cycloaddition of vinylogous amide 19a (Scheme 4).  Advancements in a
symmetric Diels-Alder cycloadditions would permit use of catalytic amounts of a Lewis
acid to facilitate the construction of the central cyclohexene ring.12a,12b,12c  Amide 19a
could be obtained from the coupling of amine 20a and acid 21,  in turn derived from
racemic tartaric acid (22) and urea (23).  Ring-opening aminolysis of lactam 18 would be
followed by conversion of the imidazolones to aminoimidazoles and incorporation of the
bromopyrroles to deliver racemic ageliferin.  Having established the validity of this
approach, R-(-)- phenylglycinol or S-(+)-phenylglycinol might be used to induce
asymmetry in the IMDA yielding optically active 18a.  A proposed transition state
arrangement is shown (Scheme 4).  It is reasonable to suggest that either enantiomer of
ageliferin will be produced by proper choice of chiral inductor (Scheme 4).  Other
members of the Romo group have investigated synthetic strategies toward axinellamine,
palau’amine, and phakellin.  Anja Dilley demonstrated that protection of  the
imidazolone nitrogen as a sulfonamide adds more stability to the diene system thus
increasing the yield of the IMDA cycloaddition and most importantly the
regioselectivity.45   In addition, deprotection of the benzyl groups from the nitrogen on
the imidazolone rings usually required relatively harsh conditions.  It was also
10
demonstrated that tosyl and dimethoxylbenzyl (DMB) protecting groups are ideal
protecting groups likely compatible with functionality present in the latter stages of the
synthesis of axinellamine and palau’amine.
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In 1981, Mukaiyama and Iwasawa reported the asymmetric IMDA process using
(-)-phenylglycinol as linker, which led both to the effective transfer of chirality and to
acceleration of the reaction (Scheme 5).12
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We considered extentending this method to an enantioselective synthesis of
ageliferin.  Following addition of a base and various metals to 19b-c, a 7-membered
complex is proposed (Scheme 5).  The chirality transfer process is proposed to take place
via transition state arrangements 24a and 24b dictated by steric repulsions between the
benzene ring of phenylglycinol and the methylene group next to the double bond in
chelate complex 24a.  In order to minimize non-bonding steric repulsions, the approach
of the imidazolone ring to the dienophile should take place preferentially from the side
opposite to the benzene ring.  As a result of this facial selectivity, cycloadduct 25 is
expected to be the major product, when (R)-phenyl glycinol is employed.  Conversely,
(S)-phenyl glycinol should provide enantiomeric cycloadduct 26 (Scheme 6).
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2. Synthesis of  Vinyl  Imidazolone Substrates
The condensation between racemic tartaric acid (22) and urea (23) was used to
prepare vinyl  imidazolones 21 in multigram scale.  Carboxylic acid 27 was then
subjected to perbenzylation followed by diisobutylaluminum hydride (DIBAl-H)
reduction to yield alcohol 28 (Scheme 7).13  Allylic alcohol 28 was oxidized to aldehyde
29 with manganese(IV) oxide, and the chain was elongated to ester 30 by way of a
Horner-Wadsworth-Emmons (HWE) olefination.  Activation of acid 21 by formation of
a mixed anhydride and coupling with benzylamine delivered amide 31.
13
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3. Exploring the Synthesis of Diels-Alder Reaction Substrates
Our attempts to synthesize the symmetric imide 32 from coupling of amide 31
and acid 21 proved more difficult than anticipated.  Unfortunately, amide 31 was
unstable to bases such as n-BuLi and NaH.  Although amide 31 was stable when treated
with KHMDS at low temperature, upon addition of the mixed anhydride derived from
acid 21 and isobutyl chloride, isobutyl carbamate 33 was isolated as the only product
(Scheme 8).  This could be understood by delocalization of the lone pair of electrons on
the terminal nitrogen and the a ,b -unsaturation, which in turn deactivates the desired
carbonyl toward nucleophilic attack.  Thus, the N-potassium amide nucleophile
preferentially attacks the carbamate carbonyl on the mixed anhydride molecule possibly
due to both electronic and steric effects.  In addition, the desired imide 32 was not
14
produced even after increasing the steric hindrance of the neighbouring carbonyl
employing the mixed anhydride derived from pivaloyl chloride.
Scheme 8
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4. Conclusion
 The instability of a ,b -unsaturated amine and alcohol caused difficulties for the
synthesis of IMDA substrate.  Anja Dilley’s work has shown that replacing one of the
benzyl protecting groups with an electron withdrawing tosyl group brings more stability
to the diene system and increases the regioselectivity of the intermolecular Diels-Alder
reaction.  In addition, the final deprotection of the benzyl groups from the nitrogen on
15
the imidazolone rings usually needed relatively harsh conditions.  These findings should
be incorporated into future studies towards the ageliferins.
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CHAPTER III
AN  INTRODUCTION TO THERMO-RESPONSIVE, WATER-SOLUBLE
POLY-N-ISOPROPYLACRYLAMIDE (PNIPAM) POLYMERS FOR PROTEIN
PURIFICATION
1. Thermo-responsive, Water-soluble Polymers
Nature uses polymers for structure and also cellular machinery.  Most functional
biopolymers respond to external stimuli in an all-or-nothing, or at least highly non-linear
mode.14  The reason for these nonlinear responses comes from highly cooperative
interactions existing at the molecular level.  A weak interaction between two separate
but specific monomer units can turn into a large driving force for a process occurring in
the whole system when thousands of these monomer units act in concert.14  Recently,
there has been significant progress made toward extending the properties of these
biopolymers to fully synthetic functional polymers.  These synthetic polymers respond
in a desired way to external environmental stimuli such as temperature, pH, and electric
or magnetic fields.  These polymers undergo fast and reversible changes from a
hydrophilic to a hydrophobic state.15  These highly nonlinear responses of synthetic
polymers occur mainly in water, sometimes in organic solvents16 or polymer blends17.
When this stimulus-responsive behavior  occurs in aqueous solution, these polymers
have potential as interesting tools for biotechnological and medicinal research.14  Among
the synthetic stimulus-responsive polymers, temperature responsive polymers have been
the most extensively studied.  Each of these polymers has their characteristic lower
17
critical solution temperature ( LCST ).  The polymer is soluble below its LCST due to a
combination of entropic and enthalpic effects.  Above the LCST, the polymer will
precipitate out of solution presumably due to magnification of hydrophobic interactions
between the side chains at higher temperatures.18,19, 20   Addition of sodium chloride can
linearly decrease the LCST of polymers such as poly (N, N-diethylacrylamide) (PDEA).
However, the addition of SDS at concentrations up to its critical micelle concentration
can gradually increase the LCST of the PDEA.18
In aqueous solution, several N-substituted poly (acrylamides) undergo a
thermally induced, reversible phase transition.  The LCSTs of homopolymers such as
poly (N, N-diethylacrylamide) 34, poly (N-cyclopropylacrylamide) 35, poly (N-
isopropylacrylamide) 36, and poly (N-ethylacrylamide) 37 in distilled H2O have been
reported to be 33, 58, 32, and 74 ° C, respectively (Figure 4).18  Among these
homopolymers, poly (N-isopropylacrylamide) (PNIPAM) 34 has received special
attention due to its sharp phase transition temperature at 32 ° C.19
NHO
n
36: poly (N-isopropylacrylamide)
NO
n
34: poly (N, N-diethylacrylamide)
NHO
n
35: poly (N-cyclopropylacrylamide)
NHO
n
37: poly (N-ethylacrylamide)
(33 oC) (58 oC) (32 
oC) (74 oC)
Figure 4. Structures of homopolymers
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The copolymers of  PNIPAM and functionalized monomers have been found to
not only be thermoresponsive but also show inverse temperature-dependent solubility in
water.19,21  The LCST of these polymers can be adjusted by changing the structure and
loading of the functionalized monomer (Table 1).24 these thermo-responsive polymers
have enabled  the design of smart chemical catalysts with their catalytic activities
switched off and on by precipitation and redissolution depending on reaction
temperature,22,23   In addition, these polymers have been used as tools for protein
purification25  and synthesis.24
Table 1. Structure and LCST of some PNIPAM  polymer variants
NH NH OO O O
O
O
m n q
38a: m=10, n=0, q=1
38b: m=20, n=0, q=1
38c: m=20, n=1, q=1
38d: m=20, n=5, q=2
Entry Polymer m n q LCST
1 38a 10 0 1 30 ° C
2 38b 20 0 1 28 ° C
3 38c 20 1 1 22 ° C
4 38d 20 5 2 20 ° C
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2. Affinity Chromatography
Bioactive natural products are useful probes for various cellular processes, by
serving as affinity reagents for purification of cellular receptors.  These studies can lead
to unraveling of various cellular process.  Affinity chromatography, a simple, relatively
inexpensive and very rapid process, has been the method of choice for isolating and
purifying many biomolecules from complex mixtures.26a,26b,26c   Because of the solid state
of the matrix typically employed, traditional affinity chromatography techniques suffer
from a few limitations.  The first problem is nonspecific binding, since swollen resins
and porous affinity beads can easily trap nonspecific proteins.  The second limitation
arises from the insolubility of the matrix which in turn does not allow analysis and
integrity of the loaded ligand or allow measurement of ligand loading.  One possible
solution to these limitations is the use of thermoresponsive, water-soluble copolymers
e.g. 38a (Table 1). The physical properties of these polymers argue for their application
as a matrix in protein isolation and purification.  Polymer 38a is soluble in aqueous
solution at 4 ° C and precipitates once the mixture reaches 32 ° C.  By employing this
polymer, it may prove possible to decrease the nonspecific binding relative to traditional
techniques.  Furthermore, due to their solubility, thus may enable determination of
ligand loading using such standard analytical techniques as 1H NMR.  Mattiasson and
coworkers have examined copolymers 40 of PNIPAM/1-vinylimidazole copolymers
loaded with Cu (II) ion as a potential matrix for affinity purification to purify metal
affinity proteins from a variety of cereals (Figure 5).25    The success of this first report
suggested the potential of thermoresponsive polymers as an affinity matrix.  While
elegant, this experiment was still plagued by some limitations.  First, the target proteins
needed to have a high affinity for the metal loaded on the polymer.  Secondly, the metal
ions add a net positive charge to the copolymer, which increases the LCST.  Reasoning
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that an increase in the ionic strength of the solution would facilitate the precipitation of
these metal-bound copolymers, Mattiason and coworkers tried to compensate for this
LCST change by adding NaCl.  As a result, these two limitations prevent copolymer 40
from becoming an effective general matrix for protein isolation.  Subsequently, the same
research group reported thermo-responsive copolymer 41 consisting of N-
vinylcaprolactam and 1-vinylimidazole (VI) and fully characterized 41 using static and
dynamic light scattering and 1H NMR (Figure 5).27   This research provides the ground
work  for the application of thermo-responsive, water-soluble polymer for metal-chelate
affinity precipitation techniques.  Unfortunately, the LCST of polymer 41 is 48 ° C, a
temperature which would lead to denaturization of most proteins.  In 2001, Freitag
reported synthesis of affinity macroligand bearing 2-iminobiotin at the termini to purify
avidin from crude cell extracts (Figure 5).28   The advantage to this approach due to its
low ligand loading is that addition of ligands changes the properties of the polymer only
incrementally.
n m
HN O
40
NHO
n m
N
41
n
S
H
N
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NHHN
N H
S
N
N
O N
N
42
H
Figure 5.  Structures of copolymers and macroligands
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CHAPTER IV
INVESTIGATIONS OF PNIPAM POLYMERS  AS  MATRICES  FOR
NATURAL PRODUCT CELLULAR RECEPTOR ISOLATION
1.  Introduction
The goal of this research project was to explore the possibility of using
thermoresponsive polymers for isolation of small molecule (e.g. natural products)
protein receptors.  As proof of principle, a dexamethasone macroligand 43 was designed
to isolate the glucocorticoid receptor.  In addition, we designed a cyclosporin A
macroligand for isolation of the cyclophilins.  The purpose of choosing these two ligands
follows: (1) The glucocorticoid receptor is very sensitive to temperature and protease
activity,30  therefore the dexamesosone macroligand can be used to test whether this
system can be used to isolate sensitive natural product receptors; (2) Cyclosporin A has a
number of robust protein receptors, known as cyclophilins, with different levels of
abundancy in many commercial available cell lines.29  Thus, it is an ideal model to test
both the feasibility and sensitivity of the soluble polymer system. Dexamethasone
macroligand 43, and cyclosporine A macroligand 44 are shown in Figure 6.
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43: Dexamethasone Macroligand
44: Cyclosporin A Macroligand
Figure 6.  Structure of dexamethasone macroligand (43)   cyclosporin A
macroligand (44)
2. Synthesis and Characterization of a Dexamethasone-PNIPAM Macroligand:
Application to the Isolation of the Glucocorticoid Receptor
The glucocorticoid receptors are the best characterized eukaryotic transcription
factors.30  The binding of steroids to these receptors leads to activation of these
complexes in the cytosol,31 enabling entry into the nucleus and binding to DNA via a
zinc finger domain to effect gene transcription.32, 33  The high affinity between
glucocorticoids and their receptors make them ideal for proof of principle of new
matrices to be used for protein affinity isolation.31  Synthesis of the dexamethasone
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macroligand  began with the oxidative cleavage of the hydroxyketone of dexamethasone
45 to give the dexamethasone acid 46 in moderate yield (Scheme 8).34  Amide 47 was
formed by  EDCI coupling between mono-N-Boc-1,9-diamine and acid 46. Removal of
the N-Boc carbamate was achieved upon exposure to trifluroacetic acid (TFA), which
delivered the amine-TFA salt 37.35  Initially, several methods were explored to freebase
the amine-TFA salt to facilitate coupling to the polymer.  However, the amine-TFA salt
48 was determined to be unstable during prolonged exposure to basic conditions.
Although free-basing with aqueous sodium bicarbonate solution followed by rapid
EtOAc extraction could partially freebase before decomposition, the amine-TFA salt 48
was best directly employed in coupling to polymer under basic conditions. The coupling
reaction proceeded smoothly affording the dexamethasone macroligand 43a-d with
varying ligand loadings (Scheme 8).  Although repetitive precipitation between a two
organic solvent system (THF and hexane) followed by filtration is one typical method
applied for purification of the parent polymer,17  we found that significant quantities of
macroligand were lost during the repetitive filtration process in small scale reactions.
Later we found that except for the final filtration, centrifugation can be applied to
separate the macroligand from the solvent.  In this way, the yield of this coupling
reaction was markedly improved.
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Characterization including integrity of dexamethasone and degree of loading of
dexamethasone was determined by 1H NMR (Figure 7).  In addition, we were able to
measure the solubility of the macroligand in water at 4 ° C.  As expected, when the
loading was relatively low (i.e. 43b, 43c, and 43d), the dexamethasone-polymer
macroligand exhibited physical properties similar to the parent polymer 38c.  When the
loading was high (i.e. 43a), the macroligand was insoluble in most organic solvents and
water.  This may be explained by the fact that this macroligand is highly hydrophobic.
Thus, with relatively high loading of the ligand, the ligands themselves may tend to
aggregate together.  Obviously, when employing hydrophobic natural products, one
should minimize ligand loading to ensure that the matrix solubility remains similar to
that of the parent polymer 38c.
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43b (1: 30) 25
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                 a  Expected m:n ratio based on stoichiometry of reagents 
              employed.  Actual ratio based on 1H NMR integration 
              given in parentheses.
(b)
Figure 7.  Structure, water solubility data, and 1H NMR (500 MHz, DMSO-d6) spectra
of dexamethasone-polymer macroligand 43a-d.  (a) structure and water solubility of
dexamethasone-macroligands synthesized;  (b) expansion of 1H NMR ( d  3.5-6.5) spectra
showing relative ratio of ligand to polymer based on relative integration of Ha and Hb
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In order to compare affinity precipitation with traditional affinity
chromatography, we also synthesized the dexamethasone-linker-biotin complex 51
(Scheme 9).
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We explored the application of macroligand 43 for isolation of the glucocorticoid
receptor from rat liver,  however, we were unable to isolate the glucocorticoid receptors.
We considered the possibility that the problem may stem from unsuccessful covalent
attachment of dexamethasone ligand to the polymer.  We first tried to use thin-layer
chromatography (TLC) to see if the free ligand was simply trapped in the polymer.  The
mobility of the polymer on TLC obscured these results :  In none polar solvents, the
polymer and free ligand remained at the baseline.  When more polar solvents were
employed, the polymer always streaked, thus masking everything under it.  Ultimately,
we found some evidence for covalent attachment by 1H NMR line broading (Figure 8).
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Figure 8.  Comparison of width at half-height in 1H NMR (500 MHz, DMSO-d6) of Hb
in (a) macroligand 43c (w1/2 = 4.55 Hz) versus  (b) mixture of dexamethasone amine 48
and PNIPAM 36 (w1/2 = 4.12 Hz)
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As can be seen there is an increase of 0.43 Hz in the signal corresponding to Hb
in macroligand 43a, suggestive of attachment resulting in line broadening due to
restricted tumbling.  To ensure our ability to isolate the glucocorticoid receptors by
traditional affinity methods, we used the biotin-dexamethasone conjugate 51 to isolate
dexamethasone receptors from the same batches of rat liver cytosol used in the previous
affinity experiment with the dexamethasone macroligand.  The failure to isolate the
receptors by traditional methods revealed that the previous unsuccessful affinity
experiment using dexamethasone-polymer complex may stem from the rat liver cytosol
preparation.  In addition, it is known that the concentration of glucocorticoid receptors in
normal rat liver is very low,47,50  and traditional purification methods typically used
adrenalectomized rats which induces overexpression of glucocorticoid receptors to
facilitate the isolation procedure.  However, we were unable to obtain adrenalectomized
rats.  Furthermore, the glucocorticoid receptor is very sensitive to temperature and
proteases.36  Thus, we concluded that the glucocorticoid receptor may not be an ideal
proof of principle system.  However, we recognized that it is a potentially ideal future
candidate to test whether the polymer affinity system can be applied to the isolation of
sensitive receptors.
3. Applying a Cyclosporin A-polymer Macroligand to Isolate Cyclophilins
The unique pharmacological profile of cyclosporin A (CsA) as an
immunosuppressive drug has led to great interest from both chemists and biologists.
Cyclosporin A is currently used clinically to prevent organ rejection in transplant
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patients.  When CsA traverses the cell membrane, it becomes tightly bound by a
cytosolic protein cyclophilin A.29,38   The CsA-cyclophilin A complex then binds to and
inhibits the protein phosphatase activity of calcineurin, an essential mediator of calcium
signaling in T cells, affecting cellular signaling.39,40,41  Cyclophilins not only contain a
superfamily of cellular proteins with peptidyl-prolyl isomerase activity, but also have an
effect in diverse cellular processes.42,43  Due to the abundance of several known
cyclophilins (e.g. 18, 19, 40, 58, 60, 80, 95, 180 kD) and their known stability,37a,39 we
decided to use CsA-macroligand for our second proof of principle studies.
We initially sought to connect the polymer to a linker bearing a terminal alkene.
Exploiting olefin metathesis as recently described by Diver and Liu,37a  the terminal
olefin in the polymer would then serve as a point of attachment of CsA.  Importantly,
this strategy might be generally applicable for attachment of other alkene-modified
natural products.  Alkylation of succinimide 52 gave imide 53,12  which was
subsequently treated with 1,2-ethanediamine to give the linker diamide 54 (Scheme
10).13  Coupling of diamide 54 and PNIPAM 38c utilizing previously established
conditions, afforded polymer-ligand complex 55.  We next turned our attention to the
olefin metathesis reaction using Grubbs’ second generation ruthenium catalyst.37  We
used trans-b -methylstyrene as a model olefin for the cross coupling prior to the use of
CsA.14  However, it appeared that  cross-linking of the polymer was faster than coupling
to styrene, since the final product formed was a sticky gel-like material that was not
soluble in many common organic solvents unlike the parent polymer.  This precluded
analysis and characterization by 1H NMR.
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In order to attach CsA to the polymer, a suitable linker had to be synthesized.
Synthesis of a protected linker began with the w -undecynl alcohol (57). The alcohol was
transformed into azide 58 under Mitsunobu conditions (Scheme 11).52  Reduction of the
azide moiety  under Lindlar reduction conditions resulted in simultaneous reduction of
the alkene.  Chemoselective reduction of the azide 58 was successful upon exposure to
triphenylphosphine in wet THF, releasing the primary amine 59.  Finally, the primary
amine was masked as the Cbz-carbamate 60 under standard conditions.
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We next began exploring the olefin metathesis reaction between CsA 61 and
amine 60 (Scheme 12).  However, the cross-coupling reaction did not go to completion
even in the presence of excess  amine 60.  Because the adduct 62 cannot be separated
from the starting cyclosporin A by column chromatography, a small amount of CsA was
sacrificed during the next deprotection step.  Removal of the Cbz-protecting group from
CsA derivative 62 led to amine 63, which differs significantly in TLC behavior from
CsA, thus allowing chromatographic separation.
During the formation of the macroligand 64a, we need to deal with the following
several conditions carefully:  1) Since the product 62 was relatively polar, it was not
very easy to get absolutely clean 62 without the contamination by some yellow
byproduct.  Although a second column chromatography could be used to improve the
purity of the product 62, the yield of the reaction would be decreased.  Later we found
that if continue the next reaction without considering the contamination, we can get rid
of the color finally.  2) When 62 was exposed to ethanol too long during the
deprotection, N-ethylated 63 was obtained.  So it is better to stop the reaction as soon as
it finishes.  3)  The purification process to get final macroligand 64a was not too easy.
During the repetitive precipitation, the tiny power-like 64a often clung to the filter
funnel.  When 64a was dry, it was too light to transfer to the flask.  The best method to
solve this problem was to transfer 64a during wet condition to the flask.  Then connect
the  flask to high vacuum to remove the excess solvent.
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As we required low levels of CsA loading, measurement of the loading became
difficult as it approached the detection limits of the 1H NMR.  Furthermore, unlike the
dexamethasone-polymer complex, which has a diagnostic and well resolved olefinic
proton signal to use for integration, CsA does not have any characteristic peaks for
integration.   We finally chose one of the  CsA amide peaks in the proton NMR as a
fingerprint for CsA.  However the relative magnitude of this peak became very low at
low loadings, thus allowing for a greater degree of uncertainty in measurements of
loading by integration.  Adding to these difficulties is the poor quality of the proton
NMR spectra of CsA in DMSO-d6.  As a result of these problems, we could only make
an approximation about the CsA loading by 1H NMR spectroscopy in deuterated
chloroform (Figure 9).
Alternatively, we also considered several other methods to synthesize
cyclosporin A derivative with a terminal amine.  However, each of these methods had
limitations.  As a first approach, we were considered  an olefin metathesis between the
CsA and w -undecylenyl azide 58.  Unfortunately, the yield of this reaction is very low.
A second strategy was use of an N-phthalimide protected amine to cross-metathesize
with CsA.  Finally, a deprotection of the imide would produce the desired CSA-linked
amine.  Much to our surprise, the olefin metathesis between CsA and N-phthalimide  led
to a mixture of products with a broad (M-14, M-28, M-42, M+14) mass range suggestive
of degradation by cross metathesis of the starting substrates.
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Figure 9.  Structure and 1H NMR spectra of 64a
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Critical to the success of this project was the determination of the appropriate
amounts of a ligand required to ensure precipitation of the polymer around 30 ° C o less.
To address these issues, we collaborated with Dr. Bergbreiter’s group for the synthesis
of polymers 38d, 38e, 38f (Scheme 13).  These three polymers showed reasonable water
solubility under certain conditions.  We found that benzylamine had a remarkable effect
on the solubility of these polymers.  Trace amounts of  benzylamine, attached to
polymers 38d, 38e, 38f after amide formation were significant and prevented dissolution
even at 4 ° C.
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We began affinity chromatography experiments with macroligand 64a and the
traditional  Sepharose-CsA beads concurrently (Figure 10).  With Sepharose-CsA, we
could see one clear band with a molecular weight of approximate 18 kD.  In the case of
the CsA macroligand, we could also see a similar 18 kD band but with less intensity.  At
this point, we cannot definitely conclude that this band is a cyclophilin since the poor
solubility of  free CsA in buffer at 4 ° C prevented us from running a true competition
experiment.  In addition, we found that the polymer-CsA was more readily precipitated
out of the buffer solution than the polymer-t-butylamine (control) after the affinity
binding.  Furthermore, the polymer 38d ( 8:1 ratio quenched with t-butylamine)
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precipitated out as small loose solid that prevented centrifugation.
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Figure 10.  Affinity chromatography experiments using CsA macroligands to isolate cyclophilins from
Jurkat cells.   a) structures of CsA macroligands 64b and 64c used in affinity experiments. b) SDS-PAGE
gel from attempted affinity experiment to isolate cyclophilins: Lane 1: Sepharose-CsA complex;  Lane 2:
Polymer background 38g;  Lane 3: CsA  macroligand 64b;  Lane 4:  Molecular Weight Marker ( 6.5-20.5
kDa);  Lane 5: CsA  macroligand 64c
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One of the challenges during this affinity experiment was the fact that the
polymer-CsA macroligand itself cannot be easily precipitated out once the SDS sample
buffer was added to the system.  This would suggest that the final protein-SDS buffer
mixture contains most of the CsA-macroligand.  After separation by gel electrophoresis
and stained by Coomassie Blue, the bands seemed a little curved and broadened due to
the effect of the remaining polymer.  We tried several methods including filtration,
heating, and changing monomer ratio to cancer out the polymer background.  Among
these methods,  the most effective one we have found was that  after adding the SDS
sample buffer, heating the total solution in boiling water for 7 min  and then centrifuge at
14000 rpm, 34 ° C for 5 min. Once the solid was discarded, the liquid was subjected to
this heating-centrifugation cycle two additional times.  By this method, we were able to
remove most of the polymer-macroligand from the protein solution and abtain  cleaner
gels (Figure 11).  The next goal of this research will be to use sangliferin A to perform a
competition experiment to ensure that the 18 kD band came from specific binding
instead of nonspecific trapping in the matrix.
In the future, sanglifehrin A will be used in competition experiments due to its
greater solubility.  If the cyclosporin A macroligand enables isolation of the
cyclophilins, it will be useful to reinvestigate  the dexamethasone macroligand to
determine if this methodology can be employed to purify sensitive receptors.
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1:  Polymer-CsA complex 64c ( washed one time);  2:  Same with 1 except adding free
CsA  for competition  ( Free CsA not dissolve at 4 °C);  3: Molecular  Marker; 4:  Initial
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Figure 11.  Affinity gel for attempted cyclophilin isolation
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CHAPTER V
CONCLUSION
Two natural products dexamethasone 45 and cyclosporin A 61have linked to a
PNIPAM polymer 38 to provide macroligands for affinity chromatography. Analysis of
these macroligands by 1H NMR allowed us to determine approximate ligand loadings by
intergration.  We provided evidence for covalent attachment of dexamethasone and the
polymer by measuring 1H NMR line broadening in attached dexamethasone.  We also
found it simple to determine the ligand loading for the dexamethasone macroligand but
not the cyclosporin A macroligand since the former has a very highly characteristic vinyl
proton.   We found, as expected, that if the ligand loading is relatively low, the
macroligand shows similar water solubility to the mother polymer.  It dissolved very
well in water at 4 ° C and precipitated around 35 ° C.  The dexamethasone polymer
macroligand, also indicated that if the ligand is very hydrophobic and loading is
relatively high, the macroligand cannot dissolve well at 4 ° C.  We also attempted initial
studies toward use of  these macroligands to purify their respective receptors.  In the
case of the dexamethasone affinity experiment, we did not get the desired receptors
partly due to the instability of the glucocorticoid receptor.  We  also conducted affinity
experiments with a cyclosporin A macroligand.  While we have not definitely
determined if the desired cyclophilins were isolated due to the lack of an effective
competition experiment, we determined an effective method to clear the polymer before
applying to gel electrophoresis.
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CHAPTER VI
EXPERIMENTAL PROCEDURES
1. General
All non-aqueous reactions were carried out under nitrogen atmosphere in oven-
dried (120 °C) glassware unless noted otherwise.  Tetrahydrofuran (THF) and diethyl
ether (Et2O) were distilled immediately prior to use from sodium metal/benzophenone
ketyl.  Methylene chloride (CH2Cl2, EM Science) and benzene (EM Science) were
distilled from calcium hydride prior to use.  Methanol (MeOH, EM Science) was
distilled from magnesium methoxide. Triethylamine (Et3N, EM Science), 2,6-lutidine
(Acros) and pyridine (py., EM Science) and diisopropylamine (EM Science) were
distilled from calcium hydride immediately prior to use.  The molarities indicated for
organolithium reagents were established by titration with 2,6-di-tert-butyl-4-
methylphenol and 1,10-phenanthroline as the indicator.  All other commercially obtained
reagents were used as received.  Brine refers to a saturated aqueous solution of sodium
chloride.  Rochelle’s salt solution refers to 2  M aqueous sodium potassium tartrate.
Infrared spectra were recorded with a Nicolet Impact 410 FTIR spectrometer. 1H
NMR and 13C NMR spectra were recorded on an Inova-500, Unity-300, VXR-300, or
spectrometer.  1H NMR chemical shifts are reported as d  values in ppm relative to
tetramethylsilane (TMS, 0.00 ppm), residual CHCl3 (7.24 ppm), residue acetone (2.05
ppm) or residual C6H6 (7.16 ppm).  
1H NMR coupling constants (J) are reported in Hertz
(Hz), and multiplicities are indicated as follows: s (singlet), d (doublet), t (triplet), q
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(quartet), quint (quintet), m (multiplet), br s (broad singlet), app (apparent), dd (doublet
of doublets).  Unless otherwise indicated, deuterochloroform (CDCl3, 77.0 ppm) served
as an internal standard for all 13C spectra.  Flash column chromatography was performed
using 60Å Silica Gel (EM Science, 230-400 mesh) as a stationary phase as described by
Still.1  Mass spectra were obtained on a VG analytical 70S high resolution, double
focusing, sectored (EB) mass spectrometer at the center for Chemical Characterization
and Analysis (Texas A&M). Thin layer chromatography (TLC) was performed using
glass-backed silica gel 60F254 (EM Science, 250 m m thickness).  Cyclosporin A was
purchased from LC Laboratories.  The N-Hydroxysuccinimido Biotin was purchased
from Sigma.  Dexamethasone-Sepharose was obtained from Professor Jun Liu’s lab
(John Hopkins University).  Cyclosporin A-Sepharose was initially obtained from
Professor Jun Liu’s lab.  It was subsequently synthesized according to the method of
him.37   Electrophoresis was performed using Mini-Protean 3 Cell Assembly ( Bio-Rad).
The gel was rinsed by shaking with The Belly Dancer (Stovall  Life Science).
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4-Carboxyimidazolin-2-one 27:  To 660 mL H2SO4 (18 M) was slowly added a mixture
of tartaric acid (22) ( 272.1 g, 1.8 mol) and urea (23) (100.0 g, 1.7 mol). The temperature
was not allowed to exceed 65 °C without external cooling. Reaction mixture was heated
to 80 °C for 24 h.  The dark brown reaction mixture was poured over ice (3 kg) resulting
in the precipitation of a brown solid. The precipitate thus obtained was isolated by
vacuum filtration and washed with H2O and acetone to give 73.2 g (45%) of 4-
carboxyimidazolin-2-one 27 as a brown solid.  Spectral data for this compound matched
that previously reported.45
HN N H
O
COOH
BnN N Bn
O
CH2OH
27 28
1,3-Bis(benzyl)-4-(hydroxymethylene)imidazol-2-one  28: To a cooled (0 °C)
suspension of NaH (6.51 g, 270.7 mmol)  in 170 mL anhydrous DMF was added 4-
carboxyimidazolin-2-one 27 (7.81 g, 60.16 mmol) and Bu4NI (4.42 g, 12.03 mmol).  The
reaction mixture was warmed to 25 °C.  After stirring for 30 minutes, benzylbromide
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(28.6 mL, 240.63 mmol) was added dropwise (4 mL/h) by syringe pump. After stirring
for 10 h at  90 °C, the reaction was carefully quenched  by addition H2O (10 mL).  The
mixture was extracted with Et2O.  The combined organic layers were washed with water
and brine, dried over anhydrous MgSO4 and concentrated in vacuo. Using distillation to
evaporate the benzylalcohol, benzylether, benzylbromide to get 5.87 g(crude) tribenzyl-
4-carboxyimidazolin-2-one.  The crude ester in 113 mL CH2Cl2 was cooled to –78 °C.
DIBAl-H in CH2Cl2 (44.3 mL, 2 M) was added to the ester solution. After stirring for 3
h at –78 °C, a solution of Rochelle’s salt was added and the heterogeneous mixture was
allowed to warm to 24 °C for 12 h. The layers were separated and the aqueous layer was
extracted with CH2Cl2. The combined organics were washed with brine, dried over
anhydrous Na2SO4 and concentrated in vacuo. Purification by flash chromatography on
SiO2  eluting with hexane:EtOAc(10:1à1:10) gave alcohol 28 (2.52 g, 36.3% for 2
steps) as a yale solid. Spectral data for this compound matched that previously
reported.45
BnN NBn
O
CH2OH
BnN NBn
O
CHO
2928
1,3-Bis(benzyl)4-(carboxaldehyde)imidazol-2-one 29: To activated MnO2 (8.0 g, 92
mmol) was added 4-hydroxymethylimidazolin-2-one 28 (868.8 mg, 2.95 mmol) as a
solution in 12 mL CH2Cl2,  rinsing twice with using 5 mL CH2Cl2 to complete the
transfer. After stirring for 4 h at ambient temperature, the reaction mixture was filtered
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through Celite and concentrated in vacuo to give aldehyde 29 (0.7144 g, 83%) as a
yellow oil. No further purification was required. Spectral data for this compound
matched that previously reported.45
BnN NBn
O
CO2Et
BnN NBn
O
CHO
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, -unsaturated Ester 30: To a cooled (0 °C) suspension of NaH ( 111.4 mg, 4.64
mmol) in 10 mL of  THF was added triethylphosphonoacetate(0.73 mL, 3.68 mmol) in
10 mL (8 mL rinse) THF.  After stirring the reaction at 0 °C for 5 min, the reaction
mixture was warmed to 24 °C amd stirred for 1 h.  A solution of aldehyde 29 (710 mg,
2.43 mmol) was slowly added in 7 mL (5 mL rinse) THF.  After stirring for 2 h, the
reaction mixture was poured over 10 mL of water. The layers were seperated and the
aqueous layer was extracted with Et2O.  The combined organics were washed with brine,
dried over anhydrous Na2SO4 and concentrated in vacuo. Purification by flash
chromatography on SiO2 eluting with hexane:EtOAc (10:1à1:5) gave a ,b -unsaturated
ester 30 (527.7 mg, 60%) as a yellow solid. Spectral data for this compound matched
that previously reported.45
BnN NBn
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, -unsaturated Acid 21: To a cooled (0 °C)  solution of a ,b -unsaturated ester 30 (63.9
mg, 0.18 mmol) in 2 mL THF was added LiOH (1 M, 2.8 mL) in a dropwise manner.
After 0.5 h , the cold bath was removed and the mixture was stirred at 24 °C for 6 h.
The reaction was quenched  by adding dilute 1N HCl until pH paper indicated pH 1-2
and the layers were separated. The aqueous layer was extracted four times with 8 mL
EtOAc, and the combined organic layers were dried over anhydrous Na2SO4 and
concentrated in vacuo to yield acid 21 as a white solid (58.9mg, 99%) in nearly
quantitative yield: Rf = 0.35 (1:3-hexane:EtOAc); IR (CHCl3) 3012, 2914, 1685, 1624,
1455 cm-1;  1H NMR (500 MHz, CDCl3) d  7.50-7.20 (m, 10H), 7.18 (d, J = 16 Hz, 1H),
6.60 (s, 1H), 5.91 (d, J = 16 Hz, 1H), 5.05 (s, 2H), 4.87 (s, 2H); 13C NMR (500 Mhz,
CDCl3) d  170.8, 153.7, 136.4, 135.7, 131.9, 129.0, 128.9, 128.3, 128.1, 127.7, 126.7,
120.1, 115.6, 113.2, 47.7, 45.4; HRMS (ESI) Calcd for C20H18N2O3 [ M+H ] : 335.1317.
Found: 335.1409
BnN NBn
O
COOH
BnN NBn
O
H
N
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, -unsaturated Amide 31: To a cooled (-78 °C) solution of acid 21 (205 mg, 0.614
mmol) in 4.5 mL THF was added Et3N 85.42 m L .  Five minutes later,
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isobutylchloroformate (76.64 m L, 0.614 mmol)  was added dropwisely to the solution.
After stirring under –78  °C for 10 minutes,  the reaction temperature was raised  to –20
°C.  And after 0.5 h, a solution of benzylamine (87.0 m L) and Et3N (85.4 m L), in THF
(2.5 mL)  was added to the reaction.  Stirring was continued  for an hour, the solvent was
evaporated, and 50 mL EtOAc was added to the reaction residue.  The solution was
washed with brine, dried over Na2SO4, and concentrated in vacuo.  Purification by flash
chromatography on SiO2 eluting with hexane:EtOAc (10:1à1:4) gave Benzylamide 31
(0.14 g, 52%) as a yellow viscous oil : Rf = 0.29 (1:3-hexane:EtOAc); IR (CHCl3) 3283,
3064, 2925, 1666, 1451 cm-1;  1H NMR (300 MHz, CDCl3) d  7.39-7.21 (m, 16H), 6.53
(s, 1H), 5.90 (d, J = 15.6 Hz, 1H), 5.67 (t, J = 5.7 Hz, 1H), 5.04 (s, 2H), 4.88 (s, 2H),
4.60 (d, J = 5.7 Hz, 2H); 13C NMR (500 MHz, CDCl3) d  128.9, 128.8, 128.7, 128.0,
127.8, 127.6, 126.7, 47.5, 45.3; HRMS (ESI) Calcd for C27H25N3O2 [ M+H ] : 424.1947.
Found: 424.2002.
BnN NBn
O
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, -unsaturated Aldehyde 69:  To a cooled (-78  °C) solution of ester 30 (212 mg, 0.59
mmol) in 7 mL anhydrous CH2Cl2  was added a 2 M solution of DIBAl-H in CH2Cl2
(1.76 mL, 3.5 mmol).  The reaction was stirred at -78 °C for 15 min, then diluted with 10
mL CH2Cl2 followed by adding addition of 9.44 g Na2SO4· 10H2O.   After vigorous
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stirring for 2 h, the reaction mixture was filtered through celite and concentrated in
vacuo to provide crude alcohol (187.6 mg, 0.59 mmol).  To activated (flame dry under
high vacuum three times, every time 1 minute) MnO2  (2 g, 23.44 mmol) was added the
above crude alcohol as a solution in 8 mL (5 mL rinse) CH2Cl2.  After stirring for 3 h at
24 °C, the reaction mixture was filtered through celite and concentrated in vacuo.
Purification by flash chromatography on SiO2 eluting with hexane: EtOAc system
(10:1à1:5)  gave of aldehyde 69 (100.3 mg, 54%) as a white solid: Rf = 0.62  (3:7-
hexane:EtOAc); 1H NMR (300MHz, CDCl3) d   9.35 ( d, J = 7.8Hz, 1H), 7.40-7.19 (m,
10H), 6.86 (dd, J = 15.9 Hz, 0.6 Hz, 1H), 6.74 (s, 1H),  6.19 (ddd, J =15.9 Hz, 7.5 Hz,
0.5 Hz, 1H), 5.08 (s, 2H), 4.92 (s, 2H); 13C NMR (300 MHz, CDCl3) d  192.5, 137.0,
136.3, 135.6, 132.1, 132.0, 129.1, 129.0, 128.6, 128.4, 128.2, 127.8, 126.5, 124.6, 120.3,
116.6, 124.6, 120.3, 116.6, 47.8; HRMS (ESI) Calcd for C20H18N2O2 [ M+H] : 319.1368.
Found: 319.0000
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Dexamethasone acid 46: To a solution of  dexamethasone 45 (1.0 g, 2.55 mmol) in 200
mL of ethyl alcohol was added a solution of periodic acid (120 mL, 0.025 M) and
sulfuric acid (3.8 mL, 2.5 M) in 75 mL distilled water.  After the reaction mixture was
stirred for 24 h at 24 °C, the ethanol was evaporated in vacuo, and the residue was
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filtered to get a crude solid. The solid was dissolved in  ethylacetate (200 mL) and
extracted three times with NaOH (0.04 M, 40 mL). The combined aqueous layers were
then acidified to pH = 2 with 2M HCl.  This solution was aged at 24 °C. Filtration of the
resulting solids gave acid 46 (0.675 g, 70 %) as a white solid.  Spectroscopic data for
this compound matched that previously reported.34
H2N NH2 H2N NHBoc
70 71
(9-Amino-nonyl)-carbamic acid tert-butyl ester 71:  To a solution of diamine 70 (1.0
g, 6.3 mmol) in 5 mL THF at 24 °C was added a solution of  (Boc)2O (0.69 g, 3.2 mmol)
in THF dropwise. After stirring overnight, the solvent was removed in vacuo, and 6 ml
of water was added.  The solution was extracted with CH2Cl2 (3 x 6 mL).  The combined
organic extracts were then washed with brine (4 x 6 mL) and dried over anhydrous
MgSO4. Filtered and concentrated.  Purification by flash chromatography on SiO2
eluting with EtOAc: MeOH: Et3N = 10:2:1 afforded mono-N-Bocdiamine 71 (0.82 g, 99
%). Spectroscopic data for this compound matched that previously reported.46
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Dexamethasone amide 47: To a solution of dexamethasone acid (234.6 mg, 0.62
mmol), (9-Amino-nonyl)-carbamic acid tert-butyl ester 71 (349.8 mg, 1.4 mmol), HOBt
(162.44 mg, 1.24 mmol) in 35 mL anhydrous CH2Cl2 was added Et3N  (0.81 mL, 5.83
mmol).  After 5 min, EDCI (498.4 mg, 2.6 mmol) in 25 mL CH2Cl2 was transferred to
the reaction mixture.  After stirring for 5 h at 24 °C, the reaction mixture was diluted
with EtOAc (250 mL) and washed with 0.1M HCl (3 x 55mL), saturated NaHCO3 (1 x
55mL), water (1 x 55mL), and then dried over Na2SO4.  Purification by flash
chromatography on SiO2 eluting with Et2O:EtOAc( 19:1à1:1) gave the Bocprotected
amide 47 (318.9 mg, 80%) as a white solid: Rf = 0.59 (1:2-Et2O:EtOAc); 
1H NMR (300
MHz, CDCl3) d  7.24 (s, 1H), 6.60 (t, J = 4.6 Hz, 1H), 6.36 (dd, J = 10.3 Hz, 2.0 Hz, 1H),
6.15 (s, 1H), 4.60 (bs, 1H), 4.39 (d, J = 9.3 Hz, 1H), 3.25 (m, 6H), 2.66 (m, 1H), 2.50-
2.10 (m, 7H), 1.90-1.70 (m, 2H), 1.60 (s, 3H), 1.48 (s, 13H), 1.33 (s, 11H), 1.16 (s, 3H),
0.97 (d, J = 7.5 Hz, 3H); 13C NMR (500 MHz, CDCl3) d  186.6, 172.3, 166.2, 152.1,
129.8, 125.1, 86.8, 72.4, 71.8, 47.9, 43.8, 39.3, 36.5, 35.2, 34.4, 34.2, 32.2, 31.1, 29.9,
29.7, 29.2, 28.8, 28.4, 27.4, 26.7, 26.5, 22.9, 17.4, 14.4; HRMS (ESI) Calcd for
C35H55FN2O6 [ M+H ] : 619.4044. Found: 619.4188
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Dexamethasone amine TFA salt 48:  To a stirred solution of amine 47 (907.5 mg, 1.5
mmol) in 17.7 mL CH2Cl2 was added 11 mL 20% TFA in CH2Cl2 solution at 0
 °C.
After 3 h at 0 °C, the reaction mixture was diluted with 80 mL CHCl3 and then the
solvent was evaporated in vacuo . Heptane (3 x 10 mL) was added to remove the excess
TFA by evaporation to get yellow gel-like amine TFA salt 48 (0.92 g, 99 %).
Spectroscopic data for this compound matched that previously reported.34
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Dexamethasone-polymer macroligand 43d: To a solution of polymer 38c (227 mg,
0.154 mmol) in 4 mL THF was added a solution of TFA amine salt 48 (9.8 mg, 0.015
mmol), catalytic amount of DMAP, and Hunig’s base (4 m L, 0.023 mmol) in 2 mL THF.
After 12 h at 24 °C, excess isopropylamine (0.1 mL 1.23 mmol) was added and the
reaction mixture was stirred overnight.  The reaction mixture was filtered through Celite
to remove the N-hydroxysuccinimide and the solvent was evaporated in vacuo. The
crude product was redissolved in 4 mL THF, and the THF solution was added dropwise
into 70 mL of rapidly stirring hexane to precipitate the polymer.  After repeating this
reprecipitation process three times, the solid was isolated by filtration and dried under
vacuum to get the product polymer 43d (205.6 mg, 75%) as a white solid.  1H NMR
51
(500 MHz, DMSO-d6) d  7.60-7.00 (m, 146H), 6.20 (d, J = 8.3 Hz, 1H), 6.00 (s, 1H),
5.23 (s, 1H), 4.60 (s, 1H), 4.08 (bs, 1H), 3.80 (s, 144H).
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Dexmethasonesuccinimiester 49:  A solution of dexamethasone acid 46 ( 85.7 mg, 0.23
mmol), EDCI (67 mg, 0.35 mmol), Et3N (0.16 mL, 1.15 mmol), N-hydroxysuccinimide
(132 mg, 1.15 mmol), and HOBt (47 mg, 0.35 mmol) in 22 mL CH2Cl2-DMF (10:1)
was stirred at 24 °C for 12 h.  Then the mixture was poured on HCl (0.1 N, 27 mL) and
the layers were separated.  The aqueous layer was extracted with EtOAc (3 x 10 mL).
After evaporating the solvent, the residue was redissolved in 45 mL EtOAc and washed
with 27 mL saturated NaHCO3 and dried over anhydrous Na2SO4. Purification by flash
chromatography on SiO2 eluting with hexane:EtOAc( 3:1à0:1) gave ester 49 (48.5 mg,
45%) as a white solid. Spectroscopic data for this compound matched that previously
reported.36, 50
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Amide 50: To a solution of diamine (60 m L, 0.52 mmol) in 8.0 mL THF was added
dropwise a solution of ester 49 ( 49.1 mg, 0.10 mmol) in 4.6 mL THF.  After 8 h at 24
°C, the solvent was evaporated in vacuo. Purification by flash chromatography on SiO2
eluting with EtOAc: MeOH: Et3N (1:3:0.2) gave amide 50 (20.4 mg, 43%) as a white
solid.  Spectroscopic data for this compound matched that previously reported.36
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Dex-Biotin complex 51:  A solution of Amide 50 (20.4 mg, 0.044 mmol), NHS-biotin
(22.5 mg, 0.066 mmol) in 1.0 mL DMF was stirred at 24 °C for 14 h. Excess DMF was
removed by freeze-drying procedure. Purification of the residue by flash
chromatography on SiO2 eluting with CHCl3: MeOH (12:1à4:1) gave 51 (19.8 mg,
65%) as a white solid. Spectra data for this compound matched that previously
reported.36
Affinity Chromatography to Isolate the Dexamethasone Receptor from Rat Liver
1) Rat liver cytosol preparation34,47 :  Livers from 40 freshly sacrificed rats were frozen
in TMG buffer containing protease inhibitor kit and stored at –20 °C.  Prior to use, they
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were thawed in water bath (37 °C) for 20 min.  All the following procedures were
performed at 4 °C.  The livers were rinced with TMG buffer containg protease inhibitor
kit and homogenized first using a waring blender then with a mortar and pestle.  The
homogenate was then spun at 35,000 rpm for 2 h to remove lipids and some cellular
debris.  The supernatant was then brought up to 1% streptomycin sulphate and
centrifuged at 10,000 rpm for 15 min to remove the ribonuclear proteins.  The
supernatant was then brought up to 0.075% protamine sulphate by addition of a 0.75%
solution of protamine sulphate drop by drop.  The solution was again centrifuged at the
same speed and time.  The resulting pellet was washed with phosphate buffer and
centrifuged at 10,000 rpm for 15 min.  This cycle was repeated an additional two times.
All washings and the previous supernatant from protamine sulphate precipitation (a total
of 105 ml) were used immediately.
2) Affinity experiment for receptor isolation:  The following  three affinity matrix were
prepared: a. 67.2 mg Dex-polymer complex, b. 57.8 mg Dex-polymer complex plus 36.8
mg free dexamethasone acid, c. 61.6 mg polymer fully quenched with isopropylamine.
The following representative procedure was the same for the above affinity matrix. Each
polymer was mixed with 35 ml of rat liver cytosol solution and shaked at 4 °C for 17 h.
The solution was then centrifuged at 11,000 rpm for 10 min at 27 °C.  The following
procedures were performed at 4 °C.  The supernatants were stored and the precipitates
were dissolved by the addition of 1.5 mL TMG buffer.  All the precipitates dissolved
very well under this condition.   A solution of dexamethasone acid (25 mg) in 2 mL
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TMG buffer was then added dropwise to the above polymer solutions and the resulting
solutions were shaken for 12 h.  The solutions were centrifuged at 11,000 rpm for 10
min at 27 °C.  Both of the precipitates and the supernatants from this step were subjected
to SDS-PAGE analysis. The SDS-PAGE gel consisted of: Resolving gel (9%) and
Stacking gel (4%).  The samples were then loaded on the stacking gel and ran at 10 mA
while the proteins were in the stacking gel.  When they entered the border between the
stacking gel and the resolving gel, 15 mA was applied to the gel.  The total running time
was around 35 min.  The gel was then stained with Coomassie blue and destained to
show the protein bands.  Unfortunately, we did not see the desired 45 kD and 90 kD
bands from the gel.
Analytical Affinity Chromatography with Biotin-Natural Product Conjugates and
Soluble Polymer-Dexamethasone Complex48,49
Part One : Cell Lysis
The entire procedure was carried out on ice or in a cold room (4 °C)
1. To 32 million cell pellet was added  2.0 mL freeze thaw buffer (10 mM CHAPS).
2. The solution was kept on ice for 10 min.
3. The solution was centrifuged at 14,000 rpm for 25 min.  The supernatant was
transferred to a clean tube and the pellet was discarded.
4. The protein concentration was measured.
Part Two : Affinity Binding
The entire procedure was carried out  in a cold room (4 °C)
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1. The lysate was aliquoted into six Eppendorf tubes, 200 µL each. Tube 1 was Setted
as DMSO control, tube 2 as Biotin-Dex binding, tube 3 as Biotin-Dex/Dex
competition, tube 4 as polymer-Dex binding, tube 5 as polymer-Dex/Dex
competition, tube 6 as PNIPAM,
2. DMSO (2 µL) was added to tube 1, DMSO (2 µL) to tube 2, Dexamethasone (2 µL,
1mM)  to tube 3, ddH2O (2 µL) to tube 4, Dexamethasone(20 µL, 1mM) to tube 5,
ddH2O (2 µL) to tube 6.  All these tubes were putted on the Belly Dancer in cold
room and kept rotating for 0.5 h.
3. DMSO (2 µL ) was added to tube 1, Biotin-Dex (2 µL, 100 µM) to tube 2, Biotin-
Dex (2 µL)  to tube 3, polymer-Dex (15 µL, 2mM) to tube 4, polymer-Dex (15 µL, 2
mM) to tube 5, PNIPAM  (15 µL, 2 mM ) to tube 6.  All these tubes were put on the
Belly Dancer in cold room and kept rotating for 1h.
4. Avidin-Sepharose CL-4B was aliquoted to another set of three Ep tubes, 20 µL each.
The tubes were spinned down at  8,000 rpm for 2 min. All the supernatant was
carefully removed.  The beads were washed two times with 200 µL of freeze thaw
buffer.  Make sure the beads amounts equal. Tubes (1-3) were transferred to the
tubes with beads and rotating for 1 h.  The tubes (4-6) were  rotated for 1 h.
5. For tubes (1-3), the tubes were spinned down at 8,000 rpm for 2 min. The
supernatants were removed and the beads were washed with 400 µL of  freeze-thaw
buffer.  The tubes were spinned down again. The beads were washed again and the
pellet beads were kept.  For tubes (4-6), they were first warmed to 32 ° C and then
spinned down at 8,000 rpm for 10 min.  After the supernatant was removed and the
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precipitate was redissolved in 200 µL of  freeze-thaw buffer, Spin down again and
the supernatant was removed and the precipitate was kept.
6. SDS loading buffer (40 µL) was added to each tube. After heated at 100 ° C for 10
min, the buffer was spinned down for 5 min at 8,000 rpm.
7.  12 µL of solution was taken from each sample and the SDS-PAGE was run with a
protein molecule marker
Part Three:  SDS-PAGE
Use 10 % Polyacrylamide Gel
Part Four:  Silver Staining
OH N3
8 8
57 58
-undecylenyl azide 58:  A mixture of w-undecylenyl alcohol 57 (1.2 mL, 6.0 mmol)
and Diphenylphosphoryl azide (1.6 mL, 7.3 mmol) was dissolved in anhydrous DMF
10mL.  After the mixture was cooled to 0 °C, neat DBU 1.1 mL was added.  The reaction
mixture was stirred at 0 °C for 2 h and then heated to 65 °C.  After the reaction was kept
at 65 °C for 5.5 h, EtOAc (50 mL) and H2O (17 mL) were added and the two layers were
separated.  The organic phase was washed with H2O (2 x 10 mL), 5% HCl (10 mL),
brine(2 x 10 mL) respectively and dried over anhydrous Mg2SO4.  Purification by flash
57
chromatography on SiO2 eluting with Et2O:hexane (1:19à1:9) gave w -undecylenyl
Azide 58 (0.83 g, 73%) as a yale solid: Rf = 0.24 (5:1-hexane:EtOAc); IR (CHCl3) 2931,
2851, 2095 cm-1;  1H NMR (300 MHz, CDCl3) d  5.90-5.77 (m, 1H), 5.04-4.90 (m, 2H),
3.25 (t, J = 6.9Hz, 2H), 2.10-2.00 (m, 2H), 1.65-1.55 (m, 2H), 1.45-1.25 (m, 12H); 13C
NMR (500 MHz, CDCl3) d  139.0, 114.0, 51.4, 33.8, 29.4, 29.3, 29.1, 29.0, 28.8, 28.8,
26.7.
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-undecylenyl amine 59: A mixture of starting Azide 58 (720.0 mg, 3.6 mmol) and
triphenylphosphine (1.0 g, 3.9 mmol) in THF 18 mL containing water 0.07 mL was
stirred at 24 °C for 18 h and then concentrated in vacuo. Purification by flash
chromatography on SiO2 eluting with CH2Cl2:CH3OH:Et3N (1:0:0.1à1:10:0.2) to afford
w-undecylenyl Amine 59 (520.3 mg, 86%) as a yale viscous oil. Spectroscopic data for
this compound matched that previously reported.50
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N-Cbz-aminal 60: To a solution of started Amine 59 (135.9 mg, 0.80 mmol) in 5 mL
dioxane was added NaOH (0.29 M, 3 mL) at 0 °C.  After the solution was stirred at 0 °C
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for 15 min,  Then Cbz-chloride dioxane solution (1 M, 0.97 mL) was added to the above
reaction mixture in a dropwise mode.  After the reaction mixture was warmed to 24 °C,
the solution was continued stirring for 14 h.  Then evaporate the dioxane in vacuo and
use dilute hydrochloric acid (1N) to adjust the solution till pH = 3-4.  The reaction
mixture was extracted with EtOAc (3 x 30 mL).  Purification by flash chromatography
on SiO2 eluting with Et2O:Hexane (1:20à5:1) gave the product 60 (194.9 mg, 80%) as a
white solid: Rf = 0.12 (1:3-Et2O:hexane); IR (CHCl3)  3334, 2919, 1701, 1532, 1255 cm
-
1;  1HNMR (300 MHz, CDCl3) d  7.40-7.30 (m, 5H), 5.90-5.75 (m, 1H), 5.10 (s, 2H),
5.05-4.90 (m, 2H), 4.82 ( br, 1H), 3.23-3.17 (br, 2H), 2.10-2.00 (m, 2H), 1.60-1.23 (m,
14H); 13C NMR (500 MHz, CDCl3) d  139.1, 114.1, 45.7, 39.9, 33.8, 31.9, 29.5, 29.4,
29.3, 29.3, 29.3, 29.0, 29.0, 28.9, 28.9, 27.6, 26.5, 22.6, 14.1, 8.6; HRMS (ESI) Calcd
for C19H29NO2 [ M+H ] : 304.2198. Found: 304.2081
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Cbz carbamate 62:  Into a flame-dried 25 mL round bottom flask equipped with a
magnetic stirbar and reflux condensor was dissolved cyclosporine A 61 (209 mg, 0.17
59
mmol), Cbz protected w-undecylenyl Amine (477.6 mg, 1.57 mmol), and 1,3-dimesityl-
4,5-dihydroimidazol-2-ylidenetricyclohexylphosphine benzylidene ruthenium dichloride
(45 mg,  0.053 mmol, 30 mol%)  in 5.0 mL CH2Cl2 and the solution was refluxed for 24
h.  After cooling to ambient temperature, the reaction mixture was concentrated in
vacuo.  Purification by flash chromatography on SiO2 eluting with hexane:EtOAc
(1:2à1:0) to give 62 (206.6 mg, 81%) as a white solid: Rf = 0.16 (1:5-Et2O:hexane); IR
(CHCl3) 3309, 2995, 2868, 2254, 1629 cm
-1; 1HNMR (500 MHz, CDCl3) d  8.03 (d, J =
10.0 Hz, 1H), 7.66 (d, J = 7.5Hz, 1H), 7.47 (d, J = 8.0 Hz, 1H), 7.38-7.28 (m, 5H), 7.16 (
d, J = 8.5 Hz, 1H), 7.69 (dd, J = 11, 4 Hz, 1H), 5.49 (m, 1H), 5.31 (m, 2H), 5.14-4.92
(m, 6H), 4.82 (m, 1H), 4.71 (d, J = 14, 1H), 4.64 (m, 1H), 4.53 (m, 1H), 3.50 (s, 3H),
3.40 (s, 3H), 3.23 (s, 3H), 3.30 (m, 2H), 3.12-3.04 (m, 6H), 2.84 (m, 4H), 2.70 (s, 3H),
2.43 (m, 1H), 2.20-0.70 (m, 86 H); 13C NMR (500 MHz, CDCl3) d  173.8, 173.7, 173.5,
173.4, 171.6, 171.2, 171.1, 170.3, 170.3, 170.1, 170.0, 136.7, 128.6, 128.4, 128.0,66.5,
64.3, 60.3, 58.8, 57.8, 57.8, 57.5, 55.4, 55.3, 55.2, 48.7, 48.5, 48.1, 45.0, 41.1, 40.5,
39.4, 38.9, 37.4, 35.9, 35.8, 33.9, 32.6, 31.5, 31.3, 31.1, 29.7, 29.7, 29.5, 29.4, 29.2,
29.2, 29.1, 29.0, 26.7, 25.3, 24.8, 24.8, 24.6, 24.4, 23.8, 23.7, 23.6, 23.4, 23.8, 23.7,
23.6, 23.4, 21.8, 21.7, 21.1, 21.0, 20.3, 19.8, 18.6, 18.3, 18.1, 16.8, 15.8, 14.1, 9.8;
MALDI-MS calcd for C78H134N12O14  [ M+Na ] : 1486.0142, found 1486.0031.
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Cyclosporin A-linker 63:  A mixed solution of   starting Cbz-Cyclosporin A-linker 62
(206.6 mg, 0.14 mmol), Pd/C (10%, 68 mg)  in 12 mL ethanol was degassed by
connecting with water aspirator then flashed the flask with hydrogen balloon.  Do this
process three times to make sure the flask is filled with Hydrogen instead of air. After
the reaction was continuing under Hydrogen for 1.5 h, the reaction mixture was filtered
through celite and concentrated in vacuo.  Flash chromatography with Et3N deactivated
SiO2 eluting with EtOAc:MeOH (1:0à0:1) to give product 63 (117.4 mg, 62%) as a
white solid: Rf = 0.16 (1:5-Et2O:hexane); IR (CHCl3) 3452, 2955, 2863, 2249, 1629,
1465 cm -1;  1HNMR(500 MHz, CDCl3) d  7.90 (d, J = 9.5 Hz, 1H), 7.61 (d, J = 7.5 Hz,
1H), 7.43 (d, J = 8.0 Hz, 1H), 7.12 (d, J = 8.0 Hz, 1H), 5.67 (dd, J = 10.5, 4.0 Hz, 1H),
5.43 (d, J = 5.5 Hz, 1H), 5.26 (dd, J = 11.5, 3.5 Hz, 1H), 5.10 (d, J = 11.0 Hz, 1H), 5.03-
4.96 (m, 2H), 4.90 (m, 1H), 4.79 (m, 1H), 4.69 (d, J = 14.0 Hz, 1H), 4.60 (t, J = 8.5 Hz,
1H), 4.83 (m, 1H), 3.67 (t, J = 6.0 Hz, 1H), 3.47 (s, 3H), 3.35 (s, 3H), 3.22 (s, 3H), 3.17
(d, J = 14.0 Hz, 1H), 3.08-3.02 (m, 10 H), 2.90 (m, 2H), 2.66 (m, 6H), 2.40 (m, 1H),
2.13-0.76 9m, 82H), 0.67 (d, J = 6.5 Hz, 3H); 13C NMR (500 MHz, CDCl3) d  173.8,
173.7, 173.5, 173.3, 171.5, 171.2, 171.0, 170.5, 170.2, 170.0, 75.3, 60.3, 58.9, 57.6,
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57.5, 55.3, 55.3, 55.2, 50.2, 48.6, 48.4, 48.1, 45.8, 45.0, 40.4, 40.0, 39.4, 38.9, 37.5,
36.4, 35.9, 34.0, 32.6, 31.5, 31.2, 31.0, 30.3, 29.7, 29.7, 29.6, 29.6, 29.5, 29.5, 29.4,
29.4, 29.1, 29.0, 28.9, 26.5, 25.2, 24.8, 24.7, 24.5, 24.3, 23.8, 23.7, 23.6, 23.4, 29.1,
29.0, 28.9, 28.1, 27.2, 26.5, 25.2, 24.8, 24.7, 24.5, 24.3, 23.8, 23.7, 23.6, 23.4, 21.8,
21.7, 21.1, 20.3, 19.8, 18.6, 18.2, 18.1, 17.0, 15.9, 14.1, 9.8, 8.8; HRMS (ESI) Calcd for
C70H130N12O12 [ M+H ] : 1331.9931.  Found: 1331.9096
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Cyclosporin A-linker
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64a
Cyclosporin A-linker-polymer 64a:   To an oven-dried 25 mL round bottom flask
dissolve polymer (135 mg,, 0.11 mmol), DMAP ( cat.) in 2 mL anhydrous THF.  Then
Cyclosporin A-linker 63 (13.8 mg, 0.010 mmol, 1.0 equiv.) in 1mL THF was added
dropwise to the reaction flask.  Finally 3 drop of Hunig’s base was added to the flask.
After the reaction was stirred for 12 h, t-butylamine ( 0.02 mL, 0.21 mmol,) was added
to the reaction flask.  After stirring at 24 °C for 9 h,  the  reaction mixture was filtered
through celite column and the reaction liquid was concentrated in vacuo. The residue
was purified by repetitive precipitation ( THF, 3 mL and Hexane, 50 mL) four times to
provide 64a (27 mg, 70%).  1HNMR ( 300 MHz, CDCl3) d  7.66 (d, 1H), 4.00 (s, 20H)
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Ester 67:  To a stirred solution of N-hydroxysuccinimide 66 (5.76 g,  50 mmol) and
triethylamine (7.67 mL, 55 mmol) in 75 mL CHCl3 at 0
 °C,  Acryloyl Chloride (5 g, 55
mmol) was added dropwisely during a 10 min period under nitrogen.  After stirring for
additional 20 min at 0 °C, the solution was washed with 120 mL ice-cold water and
saturated sodium chloride solution, respectively.  After the reaction mixture was
concentrated to a volume of 15 mL, it was dried with anhydrous Mg2SO4, and filtered
through celite,  and 1.5 mL EtOAc and 10 mL of hexane were added slowly with stirring
to the chloroform solution.  Then the total solution was left at 4 °C for 2 h.  The
precipitated white solid was separated by filtration and washed with ice-cold 5 ml
portion of a mixture of hexane: EtOAc (4:1), 5 mL portion of Hexane: EtOAc (9:1) and
two additional 5 mL portions of Hexane, respectively.  The product 67 (4.38 g, 52%)
was dried over vacuum for 10 h. Spectroscopic data for this compound matched that
previously reported.51
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Polymer 38a:  Into an oven dried 250 mL round bottom flask equipped with magnetic
stirbar and reflux condenser was dissolved N-isopropylacrylamide 68 ( 1.67 g, 14.8
mmol) and Hydroxylsuccinimide ester 67 ( 250 mg, 1.48 mmol) in 40 mL t-
butylalcohol.  The reaction flask was evaculated and flushed with N2 three times. Then
the reaction mixture was heated to 75 °C in an oil bath.  Into a separate vial was
dissolved AIBN (5.8 mg) in 8 mL t-BuOH and evaculated and flushed with N2 three
times.  After the reaction flask was stabilized under 75 °C for 1 h, the N2 flushed AIBN
solution was added to the reaction flask. After continue stirring at 75 °C for 23 h, the
reaction solution was concentrated in vacuo.  The residue was purified five times by
repetitive precipitation with a THF/hexane solvent system (THF, 20 mL and hexane, 350
mL) to give product 38a as a  white solid.  Spectroscopic data for this compound
matched that previously reported.51
Analytical Affinity Chromatography with Sepharose-Cyclosporin A Amine Conjugates
and Soluble Polymer- Cyclosporin A Amine Complex
Culturing the Jurkat-cells: The cell culture medium was defrosted by putting it in a
37 °C water bath for 40 min to let them warmed to around 37 °C.  Into a 600 ml Falcon
tissue culture flask was put 10 mL of stock Jurkat cell solution and 20 mL of flesh cell
culture medium. Then the culture flask was put into the 37 °C CO2 incubator.  After
three days, 5 mL of cell solution was sucked into another 600 mL Falcon tissue culture
flask and an additional 75 mL flesh culture medium was added into the flask.  After
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another 72 h, the growing condition of the cell was checked under microscope and the
amount of the cell was calculated.  The cell culture was transferred into centrifuge tubes
and centrifuged at 1,000 rpm for 20 min at 24 ° C.  After the supernatant was discarded,
the PBS buffer was added to wash the cell.  Then the solution was cetrifuged at 1,000
rpm for 10 min and the PBS supernatant was discarded.
The procedure of making the binding buffer (also used as lysis buffer):  To a
2500 mL beaker was added the following reagents: 20 mM Tris-HCl power 3.152g; KCl
7.456g; 0.2% Triton X-100 2 mL; H2O 800 mL.  Then use 1N NaOH to adjust the pH of
thesolution to 7.4.  Then add more water to the buffer solution until the final volume of
the solution to 1000 mL.  Store in the refrigerator (4 °C).  Everytime before use, add one
protease inhibitor pill to 10 mL of buffer.
Affinity Experiment
Part One : Cell Lysis
The entire procedure was carried out on ice or in a cold room (4 ° C)
1. All of the equipments were cooled in the cold room.
2. Cell pellet (3 x 108 ) was taken and 1.5 mL of  binding buffer (20 mM Tris HCl, pH
7.4, 100 mM KCl, 0.2% Triton X-100, 2 m g/mL each of leupeptin, aprotinin, and
soybean trypsin inhibitor) was added to the pellet.
3. The cell solution was homogenized 50 times within 15 minutes on ice.
4. The homogenate was centrifuged at 14, 000 rpm for 30 min.  The supernatant was
removed to a clean  tube and the pellet was discarded.
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5. the protein concentration was measured according to the manufacturer’s direction.
(Bio-Rad Protein assay Kit I)
Part Two : Affinity Binding
1. The lysate was aliquoted into six Eppendorf tubes and the amount of protein for each
affinity tube was around 1.2 mg. Tube 1 was set as control, tube 2 as Sepharose-CsA
binding, tube 3 as Sepharose-CsA/CsA competition, tube 4 as polymer-CsA binding,
tube 5 as polymer-CsA/CsA competition, tube 6 as Polymer (Poly-N-
isopropylacryamide poly-t-butylamine)
2. 40 µL of binding buffer was added to tube 1, 40 µL of Sepharose-CsA beads to tube
2, 40 µL of  Sepharose-CsA beads to tube 3, 60 µL of  polymer-CsA to tube 4, 60 µL
of Polymer-CsA  to tube 5, 60 µL of Polymer (Poly-N-isopropylacryamide poly-t-
Butylamine) to tube 6.  200 µL of cell lysate was put into each tube. All tubes were
put on the Belly Dancer at 4 °C rotating for 1.5 h.
3. 3 µL of CsA DMSO stock solution (17 mg/45 µL DMSO) was added to tube 3 and
tube5 respectively.  All the tubes  were kept rotating for 0.5 h at 4 °C.
4. For tubes 1-3, they were spinned down at 8,000 rpm for 2 min at 4 °C.  After the
supernatant was removed and the beads was washed with 400 µL of binding buffer.
Spinned down again and the supernatant was removed and the beads was washed
with  binding buffer again. The pellet beads was kept for future use.  For tubes 4-6,
they were warmed to 32 °C and then spinned down at 8,000 rpm for 3 min at 32 °C.
The supernatant was removed and the residue was redissolved in 100 µL binding
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buffer at 4 °C for 10 min. Then the solution was warmed to 32 °C and spinned down
at 8,000 rpm for 3 min again.  The supernatant was removed and the precipitate was
kept.
5. 40 µL of  SDS sample buffer was added to each tube. They were heated at 100 ° C
for 5 min and then the tubes were cooled to 25 °C.  The cell tubes were spinned
down for 5 minutes at 8,000 rpm at 32 °C.  The solution was kept and the residue
was discarded.
6. 18 µL solution from each tube was loaded onto the 12 % denaturing SDS-PAGE
with wide protein molecule marker.
Part Three:  Gel-staining with Coomassie Blue
The gel was stained with Coomassie Blue solution at room temperature.
1) Staining solution: Coomassie Blue R-250 2.5g; Methanol 454 mL; Acetic Acid
glacial 92 mL, Water 454 mL  2) High methanol destaining solution: Methanol 454 mL;
Acetic Acid glacial 75 mL; Water 471 mL  3) Low methanol destaining solution:
Methanol 50 mL; Acetic Acid glacial 75 mL; Water 875 mL  4) Method for destaining:
Gel in 100 mL staining solution for 40 minutes. Then shake the gel with 3 X100 mL
High methanol destaining solution for 1.5 hours three times. Then the gel was put into
100 mL Low methanol destaining solution for 8 hours.
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APPENDIX
SELECTED SPECTRAL DATA
72
1H NMR spectrum for a ,b -unsaturated Acid 21 (CDCl3)
13C NMR spectrum for a ,b -unsaturated Acid 21 (CDCl3)
73
IR spectrum for a ,b -unsaturated Acid 21
1H NMR spectrum for a ,b -unsaturated Amide 31 (CDCl3)
74
13C NMR spectrum for a ,b -unsaturated Amide 31 (CDCl3)
75
IR spectrum for a ,b -unsaturated Amide 31 (CDCl3)
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IR spectrum for Dexamethasone Amide 47 (CDCl3)
13C NMR spectrum for Dexamethasone Amide 47 (CDCl3)
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1H NMR spectrum for Dexamethasone Amide 47 (CDCl3)
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81
  1H NMR spectrum for w -undecylenyl Azide 58 (CDCl3)
13C NMR spectrum for w -undecylenyl Azide 58 (CDCl3)
82
 IR spectrum for w -undecylenyl Azide 58
1H NMR spectrum for N-Cbz-Aminal 60 (CDCl3)
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13C NMR spectrum for N-Cbz-Aminal 60 (CDCl3)
IR spectrum for N-Cbz-Aminal 60 (CDCl3)
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1H NMR spectrum for Cbz Carbamate 62 (CDCl3)
13C NMR spectrum for Cbz Carbamate 62 (CDCl3)
85
 IR spectrum for Cbz Carbamate 62
86
1H spectrum for Cyclosporin A-linker 63 (CDCl3)
 13C spectrum for Cyclosporin A-linker 63 (CDCl3)
87
 IR spectrum for Cyclosporin A-linker 63 (CDCl3)
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13C NMR NMR spectrum for a ,b -unsaturated Aldehyde 69 (CDCl3)
90
VITA
Name Min Zhou
Date of Birth May 28, 1976
Place of Birth Yixing, China
Education B.S., July, 1998, Pharmaceutical Chemistry
Beijing Medical University
Beijing, P.R. China
Permanent Address Hutai Road 1021, Shanghai
P.R. China
Publication Liu, Z. J.; Zhou, M.; Min, J. M.; Zhang, L. H.
“Syntheses of 5’-O-Glycosylnucleosides.”
Tetrahedron: Asymm. 1999, 10,  2119—2127
